Atossa Therapeutics Statistics Share Statistics Atossa Therapeutics has 129.17M
shares outstanding. The number of shares has increased by 2.71%
in one year.
Shares Outstanding 129.17M Shares Change (YoY) 2.71% Shares Change (QoQ) 0% Owned by Institutions (%) 21.95% Shares Floating 129.12M Failed to Deliver (FTD) Shares 950 FTD / Avg. Volume 0.09%
Short Selling Information The latest short interest is 3.66M, so 2.83% of the outstanding
shares have been sold short.
Short Interest 3.66M Short % of Shares Out 2.83% Short % of Float 2.83% Short Ratio (days to cover) 5.42
Valuation Ratios The PE ratio is -4.66 and the forward
PE ratio is -2.75.
Atossa Therapeutics's PEG ratio is
0.28.
PE Ratio -4.66 Forward PE -2.75 PS Ratio 0 Forward PS 1.9 PB Ratio 1.66 P/FCF Ratio -5.65 PEG Ratio 0.28
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Atossa Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 14.99,
with a Debt / Equity ratio of 0.
Current Ratio 14.99 Quick Ratio 14.99 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.7M Employee Count 15 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -40.6% in the
last 52 weeks. The beta is 1.1, so Atossa Therapeutics's
price volatility has been higher than the market average.
Beta 1.1 52-Week Price Change -40.6% 50-Day Moving Average 0.82 200-Day Moving Average 0.86 Relative Strength Index (RSI) 50.61 Average Volume (20 Days) 1,115,077
Income Statement
Revenue n/a Gross Profit -17K Operating Income -27.62M Net Income -25.5M EBITDA -25.49M EBIT -25.5M Earnings Per Share (EPS) -0.2
Full Income Statement Balance Sheet The company has 71.08M in cash and 0 in
debt, giving a net cash position of 71.08M.
Cash & Cash Equivalents 71.08M Total Debt n/a Net Cash n/a Retained Earnings -211.79M Total Assets 64.52M Working Capital 55.7M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -21.03M
and capital expenditures -19K, giving a free cash flow of -21.05M.
Operating Cash Flow -21.03M Capital Expenditures -19K Free Cash Flow -21.05M FCF Per Share -0.17
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ATOS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ATOS is $7,
which is 786.1% higher than the current price. The consensus rating is "Buy".
Price Target $7 Price Target Difference 786.1% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 20, 2018. It was a
backward
split with a ratio of 1:12.
Last Split Date Apr 20, 2018 Split Type backward Split Ratio 1:12
Scores Altman Z-Score 3.31 Piotroski F-Score 1
